3DCeram and SINTX collaborate to develop silicon nitride-based Additive Manufacturing for biomedical applications
3DCeram Sinto Inc, Bonnac-La-Côte, France, and SINTX Technologies, Inc, Salt Lake City, Utah, USA, are collaborating to develop multiple novel resins and processes for the Additive Manufacturing of biomedical ceramic products. The companies aim to leverage and further develop their existing expertise to produce unique, high-value resins and AM ceramic components that will be subjected to advanced thermal processing.
TRUSTED BY INDUSTRY’S BIGGEST NAMES
Discover how we help leading brands shape the industry conversation
| Contact us |
“We are excited about the possibilities of creating a silicon nitride-based resin for the biomedical market. With interest in silicon nitride medical devices continuing to grow rapidly, we believe 3D printed silicon nitride devices will play a major role in the future of medical and technical segments in which we participate,” said Dr Sonny Bal, CEO of SINTX Technologies. “We believe that SINTX’s resin formulation and densification expertise, combined with 3DCeram’s production scale printers, will provide the market with components of superior quality.”
SINTX and 3DCeram anticipate that the results of their collaboration will lead to wider adoption of Additive Manufacturing of advanced ceramics.
Michael Halsband, Sinto America’s CEO added, “There has been interest for these types of capabilities across the globe. The investment casting industry specifically has a strong need for a silica-based resin. If we are successful, this collaboration will provide game changer solutions within these industries.”
